ISRCTN63027630已完成2 期
A randomised phase II/III trial of induction chemotherapy followed by Continuous Hyperfractionated Accelerated Radiotherapy (CHART) versus CHART alone in patients with inoperable non-small cell lung cancer
Medical Research Council (UK)0 个研究点目标入组 46 人开始时间: 2005年9月21日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 46
研究概览
简要总结
2010 results in http://www.ncbi.nlm.nih.gov/pubmed/20932667
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Histologically or cytologically confirmed stage I-III NSCLC, considered suitable for chemotherapy and CHART
- •2. Inoperable disease as assessed by a lung cancer MDT with thoracic surgical input
- •3. Previously untreated by chemotherapy or radiotherapy
- •4. Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1
- •5. No prior or current malignant disease likely to interfere with protocol treatment
排除标准
- •1. Medically unstable (e.g. unstable diabetes, uncontrolled arterial hypertension, infection, hypercalcaemia or ischaemic heart disease
- •2. Previous or current malignant disease likely to interfere with protocol or comparisons
- •3. Women who are pregnant or lactating
- •4. Women of childbearing potential who are not practising adequate contraceptive precautions
研究者
相似试验
已完成
2 期
Nab-Paclitaxel and Cisplatin or Nab-paclitaxel as Induction Therapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck (HNSCC)Squamous Cell Carcinoma of the Head and NeckCarcinoma, Squamous Cell of the Head and NeckCancer of Head and NeckCancer of the Head and NeckHead and Neck CancerNeoplasms, Head and NeckNCT02573493Washington University School of Medicine96
进行中（未招募）
1 期
Comparison of two treatment arms of patients with non-small cell lung cancer. Patients of one arm receive the authorized infusion Durvalumab after chemotherapy, chemotherapy with radiotherapy and optional resection. Patients in the second treatment arm receive Durvalumab from the beginning, in parallel with standard therapy.non-small cell lung cancer stages IIIA (N2) and selected resectable stages IIIBMedDRA version: 21.1Level: PTClassification code 10061873Term: Non-small cell lung cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2019-000058-77-DEniversity Hospital Essen90
Unknown
3 期
Accelerated Hypofractionated vs. Conventionally Fractionated Concurrent CRT for LS-SCLCSCLCNCT02990780Shanghai Chest Hospital266
已完成
2 期
A Phase II study to evaluate the efficacy and safety of PTK787 in patients with metastatic cutaneous melanomaMetastatic cutaneous melanomaCancerISRCTN00191981Cambridge University Hospitals NHS Foundation Trust (UK)34
终止
2 期
Induction Chemo Then Concurrent Chemoradiotherapy With Cetuximab in Locally Advanced Head and Neck Squamous Cell CancerHead and Neck Squamous Cell CancerNCT01326923Louisiana State University Health Sciences Center Shreveport7